207 related articles for article (PubMed ID: 28081183)
1. Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.
Beffagna G; Sammarco A; Bedin C; Romualdi C; Mainenti M; Mollo A; Cavicchioli L; Ferro S; Trez D; De Maria R; Nitti D; Saccani A; Campanella M; Agostini M; Zappulli V
PLoS One; 2017; 12(1):e0169454. PubMed ID: 28081183
[TBL] [Abstract][Full Text] [Related]
2. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
3. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
4. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: An immunohistochemical and prognostic study.
Dolka I; Król M; Sapierzyński R
Res Vet Sci; 2016 Apr; 105():124-33. PubMed ID: 27033920
[TBL] [Abstract][Full Text] [Related]
6. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.
Kambayashi S; Ono N; Tone T; Baba K; Okuda M
Vet Comp Oncol; 2024 Jun; 22(2):303-309. PubMed ID: 38287199
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors.
Kato Y; Asano K; Mogi T; Kutara K; Teshima K; Edamura K; Tsumagari S; Hasegawa A; Tanaka S
J Vet Med Sci; 2007 Jan; 69(1):77-80. PubMed ID: 17283406
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
11. Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumors.
Lee KH; Shin TJ; Kim WH; Cho JY
Sci Rep; 2019 Jan; 9(1):175. PubMed ID: 30655558
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of TRPM7 in canine mammary tumours.
Lee S; Lee S; Kim WH
Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
[TBL] [Abstract][Full Text] [Related]
13. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
16. Detection of tumor-associated antigens in sera of canine cancer patients by monoclonal antibodies generated against canine mammary carcinoma cells.
Wang J; Brunner CJ; Gangopadhyay A; Bird AC; Wolfe LG
Vet Immunol Immunopathol; 1995 Oct; 48(3-4):193-207. PubMed ID: 8578680
[TBL] [Abstract][Full Text] [Related]
17. Short interspersed CAN SINE elements as prognostic markers in canine mammary neoplasia.
Gelaleti GB; Granzotto A; Leonel C; Jardim BV; Moschetta MG; Carareto CM; Zuccari DA
Oncol Rep; 2014 Jan; 31(1):435-41. PubMed ID: 24173085
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
19. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
[TBL] [Abstract][Full Text] [Related]
20. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
